Sugarloaf Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$155K Buy
2,737
+80
+3% +$4.47K 0.03% 196
2024
Q3
$137K Hold
2,657
0.03% 206
2024
Q2
$110K Sell
2,657
-14
-0.5% -$626 0.02% 221
2024
Q1
$145K Sell
2,671
-584
-18% -$29.8K 0.03% 193
2023
Q4
$167K Sell
3,255
-115
-3% -$6.04K 0.04% 167
2023
Q3
$196K Hold
3,370
0.05% 130
2023
Q2
$216K Sell
3,370
-388
-10% -$26K 0.05% 126
2023
Q1
$260K Sell
3,758
-771
-17% -$54.4K 0.06% 110
2022
Q4
$326K Sell
4,529
-894
-16% -$67.4K 0.08% 97
2022
Q3
$386K Buy
5,423
+354
+7% +$25.7K 0.1% 87
2022
Q2
$390K Sell
5,069
-324
-6% -$24.7K 0.1% 84
2022
Q1
$394K Sell
5,393
-1,262
-19% -$84.7K 0.09% 81
2021
Q4
$415K Buy
6,655
+683
+11% +$40.1K 0.1% 82
2021
Q3
$353K Sell
5,972
-2,574
-30% -$170K 0.09% 85
2021
Q2
$571K Sell
8,546
-2,892
-25% -$189K 0.16% 59
2021
Q1
$722 Sell
11,438
-3,265
-22% -$203K 0.22% 54
2020
Q4
$912K Sell
14,703
-43
-0.3% -$2.64K 0.31% 46
2020
Q3
$889K Buy
14,746
+74
+0.5% +$4.45K 0.32% 46
2020
Q2
$863K Buy
14,672
+343
+2% +$20.5K 0.33% 48
2020
Q1
$799K Buy
14,329
+91
+0.6% +$5.56K 0.36% 44
2019
Q4
$914K Buy
+14,238
New +$815K 0.39% 46

Other funds holding BMY

Sugarloaf Wealth Management's BMY Position: Q4 2024 in Review

Sugarloaf Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 3% in Q4 2024, buying an estimated $4.47K and bringing the position to 2,737 shares worth $155K. The position accounts for 0.03% of the portfolio, ranked #196.

Sugarloaf Wealth Management first reported a position in BMY in Q4 2019 and has held it in 21 quarters since. The position peaked at $914K in Q4 2019. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Sugarloaf Wealth Management held 2,737 shares of Bristol-Myers Squibb worth $155K as of Q4 2024.
  • Sugarloaf Wealth Management bought 80 Bristol-Myers Squibb shares in Q4 2024, an estimated $4.47K.
  • Bristol-Myers Squibb made up 0.03% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #196 holding.
  • Sugarloaf Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 21 quarters since.
  • Sugarloaf Wealth Management's Bristol-Myers Squibb position peaked at $914K in Q4 2019.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.